First use of icatibant (selective bradykinin receptor antagonist) in hereditary angioedema patients in the UK

被引：0
|
作者：
Karanam, S.
Demptser, J.
Longhurst, H.
Gompels, M.
机构：
[1] Southmead Hosp, Bristol, Avon, England
[2] St Bartholomews Hosp, London, England
来源：
CLINICAL AND EXPERIMENTAL ALLERGY | 2009年 / 39卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1943 / 1943
页数：1
相关论文
共 50 条
  • [31] Icatibant, a Selective Bradykinin-B2 Receptor Antagonist, in Acquired Angioedema Due to C1 Inhibitor Deficiency
    Bork, K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB100 - AB100
  • [32] Treatment of patients with acute attacks of hereditary angioedema due to C1-INH deficiency with the bradykinin B2 receptor-antagonist Icatibant
    Farkas, H.
    Varga, L.
    Szeplaki, G.
    Temesszentandrasi, G.
    Jakab, L.
    Fekete, B.
    Fust, G.
    Karadi, L.
    ALLERGY, 2008, 63 : 474 - 475
  • [33] Self-Administration Of a Novel Subcutaneous Bradykinin B2 Receptor Antagonist, Icatibant (Firazyr®), As An Effective Treatment Option In Patients With Hereditary Angioedema (HAE)
    Santucci, Stephanie
    Hoang Pham
    Harrison, Rachel
    Yang, William H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB31 - AB31
  • [34] Successful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibant
    Weller, K.
    Magerl, M.
    Maurer, M.
    ALLERGY, 2009, 64 : 155 - 156
  • [35] MANAGEMENT OF ADULT PATIENTS WITH ICATIBANT IN HEREDITARY ANGIOEDEMA
    Drake, David
    Sultan, Laith
    EMERGENCY MEDICINE JOURNAL, 2011, 28 (08) : 720 - 721
  • [36] Successful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibant
    Weller, K.
    Magerl, M.
    Maurer, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (01) : 120 - 120
  • [37] THE ROLE OF BRADYKININ AND THE EFFECT OF THE BRADYKININ RECEPTOR ANTAGONIST ICATIBANT IN PORCINE SEPSIS
    Barratt-Due, Andreas
    Johansen, Harald Thidemann
    Sokolov, Andrey
    Thorgersen, Ebbe Billmann
    Hellerud, Bernt Christian
    Reubsaet, Jan Leo
    Seip, Knut Fredrik
    Tonnessen, Tor Inge
    Lindstad, Julie Katrine
    Pharo, Anne
    Castellheim, Albert
    Mollnes, Tom Eirik
    Nielsen, Erik Waage
    SHOCK, 2011, 36 (05): : 517 - 523
  • [38] Acquired angioedema due to C1 inhibitor deficiency treated with icatibant, a selective bradykinin B2 receptor antagonist
    Bork, K.
    ALLERGY, 2011, 66 : 109 - 109
  • [39] A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant
    M Bas
    J Greve
    G Kojda
    H Bier
    T Hoffmann
    Critical Care, 10 (Suppl 1):
  • [40] Blocking the bradykinin response: Pharmacodynamics and safety of icatibant, a potent and selective bradykinin B2 receptor antagonist
    Zimmermann, Jens
    Rosenkranz, Bernd
    Brunner-Ferber, Francoise
    Knolle, Jochen
    MOLECULAR IMMUNOLOGY, 2008, 45 (16) : 4157 - 4157
12345